anonymouse
Guest
anonymouse
Guest
The proposed class action alleges racketeering and violations of antitrust and consumer laws by Sun, the world’s largest specialty pharmacy, and its subsidiary Ranbaxy Inc. It accuses them of fraudulently submitting bogus or missing data in applications to market generic versions of the reflux drug Nexium, the blood pressure drug Diavan, and the antibiotic Valcyte.
https://news.bloomberglaw.com/healt...ce-antitrust-suit-over-nexium-diavan-generics